Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
TCH regimen
Introduction
Synonyms and keywords:Docetaxel-Carboplatin-Trastuzumab Regimen; Taxotere-Carboplatin-Herceptin Regimen; TCH Regimen
Overview
Overview
TCH regimen refers to a sequential regimen consisting of multiple cycles of docetaxel (taxotere), carboplatin and trastuzumab (herceptin), followed by multiple cycles of trastuzumab alone, administered as a dose-dense regimen, and used in the adjuvant setting for the treatment of HER-2/neu-positive breast cancer.[1][2]
Regimen
Regimen
TDocetaxel (Taxotere)
CCarboplatin
HTrastuzumab (Herceptin)
References
References
- ↑ 1.0 1.1 Slamon D, Eiermann W, Robert N, Pienkowski T, Martin M, Press M; et al. (2011). “Adjuvant trastuzumab in HER2-positive breast cancer”. N Engl J Med. 365 (14): 1273–83. doi:10.1056/NEJMoa0910383. PMC 3268553. PMID 21991949.
- ↑ “NCI Thesaurus”.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]